Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Moleculin Biotech (MBRX) Return on Assets (2016 - 2025)

Moleculin Biotech (MBRX) has 10 years of Return on Assets data on record, last reported at 1.15% in Q3 2025.

  • For Q3 2025, Return on Assets changed 0.0% year-over-year to 1.15%; the TTM value through Sep 2025 reached 1.15%, changed 0.0%, while the annual FY2024 figure was 0.95%, 36.0% down from the prior year.
  • Return on Assets reached 1.15% in Q3 2025 per MBRX's latest filing, up from 1.18% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.19% in Q2 2021 and bottomed at 1.35% in Q1 2025.
  • Average Return on Assets over 5 years is 0.68%, with a median of 0.61% recorded in 2023.
  • Peak YoY movement for Return on Assets: skyrocketed 45bps in 2021, then plummeted -57bps in 2024.
  • A 5-year view of Return on Assets shows it stood at 0.27% in 2021, then crashed by -86bps to 0.5% in 2022, then tumbled by -47bps to 0.73% in 2023, then tumbled by -78bps to 1.29% in 2024, then grew by 11bps to 1.15% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Assets were 1.15% in Q3 2025, 1.18% in Q2 2025, and 1.35% in Q1 2025.